LOS ANGELES, CAPosted a month ago

Company overview

The USC Michelson Center Convergent Science Institute in Cancer (CSI-Cancer) is a research-focused organization dedicated to advancing cancer diagnostics and treatment through interdisciplinary collaboration and innovative technologies. It integrates expertise from engineering, biology, and medicine to develop precision oncology tools, such as liquid biopsy platforms, for early detection and monitoring of cancer. The institute is part of the University of Southern California's Michelson Center for Convergent Bioscience, established to tackle complex health challenges. CSI-Cancer generates impact by securing research grants, fostering partnerships, and translating discoveries into clinical applications. Its pioneering work positions it as a leader in transforming cancer care.